|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Canaan Partners Raises $600 Million Fund; $200 Million Will be Dedicated to the Life Sciences, Medical Device
1/10/2012 8:25:30 AM
Canaan Partners, a global venture fund with $3.5 billion under management, has raised $600 million to invest in technology and health-care companies. Canaan, based in Menlo Park, California, will spend two- thirds of the fund on digital media, Internet, mobile and other technology companies, and a third is designated for pharmaceutical, medical device and health-care investments, the company said today in a statement. This is Canaan’s ninth fund. Previous investments included Advanced BioHealing Inc., maker of Dermagraft, a bio-engineered skin substitute used to treat diabetic foot ulcers, which was acquired by Shire Plc in May for $750 million, and flash storage maker SandForce Inc., was acquired by LSI Corp. for $370M earlier this month.
|
|
|
|
|
|
|
|
|
|
|